An international group of experts has successfully implemented new therapy in the first seven COVID-19 patients. All patients treated with stem cells survived. This type of therapy has already been successfully used for other serious immune diseases.
The first results were released this month. Such results are a hope for the ability of biological therapies to combat the COVID-19 pandemic.
Leng Zikuan, Zhu Rongjia, Hou Wei, et al. ACE2- Mesenchymal Stem Cells Transplantation Improves Patient Outcome with COVID-19 Pneumonia [J]. Aging and disease, 2020, 11 (2): 216-228
original article https://www.docdroid.net/IV4zeHs/transplantation-of-ace2-mesenchymal-stem-cells-imrpoves-the-outcome-of-patients-with-covid-19-pneumonia.pdf